http://www.fibrocenter.com/ http://autoimmunedisease.suite101.com/article.cfm/fibromyalgia_treatment Low dose naltrexone is a prescription drug used off label for MS and other medical conditions. Subjects are needed for the first clinical trial of LDN in fibromyalgia. Investigators at Stanford University are recruiting patients with fibromyalgia living in the Stanford area for a clinical trial. The study is being conducted by Dr. Jarred Younger and his colleagues at the Stanford Packard Center for Translational Research in Medicine. In this double blind, placebo-controlled clinical trial, researchers are evaluating the effects of low dose naltrexone (LDN) in the autoimmune disorder fibromyalgia. Read more: http://autoimmunedisease.suite101.com/article.cfm/fibromyalgia_treatment#ixzz0HOZPxFSo&B . . .